Skip to main navigation Skip to search Skip to main content

Combination of docetaxel, trastuzumab and pertuzumab or treatment with trastuzumab-emtansine for metastatic salivary duct carcinoma

  • Wim van Boxtel
  • , Eline Boon
  • , Willem L.J. Weijs
  • , Frank J.A. van den Hoogen
  • , Uta E. Flucke
  • , Carla M L Van Herpen

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)198-200
Number of pages3
JournalOral Oncology
Volume72
DOIs
Publication statusPublished - Sept 2017
Externally publishedYes

Keywords

  • Ado-trastuzumab emtansine
  • Docetaxel
  • Head and Neck Neoplasms
  • Neoplasm metastasis
  • Pertuzumab
  • Receptor, ErbB-2
  • Salivary duct carcinoma
  • Salivary gland neoplasms
  • Trastuzumab

Cite this